logo

Health News

Share SHARE




Follow RTT
FDA Calendar
Event DateSymbolDrug NameEvent Name
04/11/17NBIXINGREZZA (NDA)FDA decision on INGREZZA for the treatment of tardive dyskinesia
04/11/17RHHBYLucentis (sBLA)FDA decision on Lucentis for the treatment of myopic choroidal neovascularization
03/29/17REGNDupilumab (BLA)FDA decision on Dupilumab for the treatment of adult patients with inadequately controlled moderate-to-severe atopic dermatitis
03/29/17SNYNF, SNYDupilumab (BLA)FDA decision on Dupilumab for the treatment of adult patients with inadequately controlled moderate-to-severe atopic dermatitis
03/28/17RHHBYOCREVUS (BLA)FDA decision on OCREVUS for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis
03/15/17MRKKeytruda (sBLA)FD decision on Keytruda for treatment of patients with refractory classical Hodgkin lymphoma
More FDA Calendar Data

FDA Device Approval
No Records Found
More FDA Device Approval Data